Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Fund Letter | Shilpa MehraFidelity Growth Strategies Fund | IDEXX Laboratories, Inc. $IDXX• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Fidelity Growth Strategies Fund 2025 Q4 (IDXX) Not holding IDEXX Labs (+6%), a maker of veterinary products and a sizable benchmark component, also hurt. IDEXX is a... | BULL | View Pitch → |
| Feb 20, 2026 | Fund Letter | Ron BaronBaron Partners Fund | IDEXX Laboratories, Inc. $IDXX• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Baron Partners Fund 2025 Q4 (IDXX) Veterinary diagnostics leader IDEXX Laboratories, Inc. spent years developing new tests. One was released... | BULL | View Pitch → |
| Jan 20, 2026 | Fund Letter | Conestoga Capital Advisors, LLCConestoga Mid Cap Composite | IDEXX Laboratories, Inc. $IDXX• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Conestoga Mid Cap Composite 2025 Q4 (IDXX) IDEXX Laboratories, Inc. (IDXX) was a major contributor during the quarter as it continued to deliver resilient organic revenue growth despite weaker veterinary visit trends. The company posted... | BULL | View Pitch → |
| Jan 8, 2026 | Fund Letter | Nik DvornakPlatinum International Brands Fund | IDEXX Laboratories, Inc. $IDXX• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Platinum International Brands Fund 2025 Q2 (IDXX) IDEXX benefits from secular growth in companion animal healthcare and increasing diagnostic penetration. Its installed base... | BULL | View Pitch → |
| Dec 4, 2025 | Fund Letter | Conestoga Capital Advisors, LLCConestoga Mid Cap Composite | IDEXX Laboratories, Inc. $IDXX• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Conestoga Mid Cap Composite 2025 Q2 (IDXX) 4. IDEXX Laboratories, Inc.... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.